Cargando…

MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia

SIMPLE SUMMARY: During cancer cachexia, patients experience profound weight loss due to metabolic dysfunction, resulting in muscle composition alterations. The proton density fat fraction (PDFF) using magnetic resonance imaging (MRI) is an established biomarker to assess changes of muscle compositio...

Descripción completa

Detalles Bibliográficos
Autores principales: Patzelt, Lisa, Junker, Daniela, Syväri, Jan, Burian, Egon, Wu, Mingming, Prokopchuk, Olga, Nitsche, Ulrich, Makowski, Marcus R., Braren, Rickmer F., Herzig, Stephan, Diaz, Mauricio Berriel, Karampinos, Dimitrios C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431175/
https://www.ncbi.nlm.nih.gov/pubmed/34503243
http://dx.doi.org/10.3390/cancers13174433
_version_ 1783750875335884800
author Patzelt, Lisa
Junker, Daniela
Syväri, Jan
Burian, Egon
Wu, Mingming
Prokopchuk, Olga
Nitsche, Ulrich
Makowski, Marcus R.
Braren, Rickmer F.
Herzig, Stephan
Diaz, Mauricio Berriel
Karampinos, Dimitrios C.
author_facet Patzelt, Lisa
Junker, Daniela
Syväri, Jan
Burian, Egon
Wu, Mingming
Prokopchuk, Olga
Nitsche, Ulrich
Makowski, Marcus R.
Braren, Rickmer F.
Herzig, Stephan
Diaz, Mauricio Berriel
Karampinos, Dimitrios C.
author_sort Patzelt, Lisa
collection PubMed
description SIMPLE SUMMARY: During cancer cachexia, patients experience profound weight loss due to metabolic dysfunction, resulting in muscle composition alterations. The proton density fat fraction (PDFF) using magnetic resonance imaging (MRI) is an established biomarker to assess changes of muscle composition. We evaluated the suitability of MRI-determined psoas and erector spinae muscle PDFF and fat volume as biomarkers for monitoring cachexia development in an oncological cohort of 58 patients and assessed the regional variation in muscle parameters over time. Our results indicate that psoas muscle PDFF and fat volume could serve as MRI-determined biomarkers for early risk stratification and disease monitoring regarding progression and severity of weight loss in cancer cachexia. ABSTRACT: Purpose: To evaluate the suitability of psoas and erector spinae muscle proton density fat fraction (PDFF) and fat volume as biomarkers for monitoring cachexia severity in an oncological cohort, and to evaluate regional variances in muscle parameters over time. Methods: In this prospective study, 58 oncological patients were examined by a 3 T MRI receiving between one and five scans. Muscle volume and PDFF were measured, segmentation masks were divided into proximal, middle and distal muscle section. Results: A regional variation of fat distribution in erector spinae muscle at baseline was found (p < 0.01). During follow-ups significant relative change of muscle parameters was observed. Relative maximum change of erector spinae muscle showed a significant regional variation. Correlation testing with age as a covariate revealed significant correlations for baseline psoas fat volume (r = −0.55, p < 0.01) and baseline psoas PDFF (r = −0.52, p = 0.02) with maximum BMI change during the course of the disease. Conclusion: In erector spinae muscles, a regional variation of fat distribution at baseline and relative maximum change of muscle parameters was observed. Our results indicate that psoas muscle PDFF and fat volume could serve as MRI-determined biomarkers for early risk stratification and disease monitoring regarding progression and severity of weight loss in cancer cachexia.
format Online
Article
Text
id pubmed-8431175
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84311752021-09-11 MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia Patzelt, Lisa Junker, Daniela Syväri, Jan Burian, Egon Wu, Mingming Prokopchuk, Olga Nitsche, Ulrich Makowski, Marcus R. Braren, Rickmer F. Herzig, Stephan Diaz, Mauricio Berriel Karampinos, Dimitrios C. Cancers (Basel) Article SIMPLE SUMMARY: During cancer cachexia, patients experience profound weight loss due to metabolic dysfunction, resulting in muscle composition alterations. The proton density fat fraction (PDFF) using magnetic resonance imaging (MRI) is an established biomarker to assess changes of muscle composition. We evaluated the suitability of MRI-determined psoas and erector spinae muscle PDFF and fat volume as biomarkers for monitoring cachexia development in an oncological cohort of 58 patients and assessed the regional variation in muscle parameters over time. Our results indicate that psoas muscle PDFF and fat volume could serve as MRI-determined biomarkers for early risk stratification and disease monitoring regarding progression and severity of weight loss in cancer cachexia. ABSTRACT: Purpose: To evaluate the suitability of psoas and erector spinae muscle proton density fat fraction (PDFF) and fat volume as biomarkers for monitoring cachexia severity in an oncological cohort, and to evaluate regional variances in muscle parameters over time. Methods: In this prospective study, 58 oncological patients were examined by a 3 T MRI receiving between one and five scans. Muscle volume and PDFF were measured, segmentation masks were divided into proximal, middle and distal muscle section. Results: A regional variation of fat distribution in erector spinae muscle at baseline was found (p < 0.01). During follow-ups significant relative change of muscle parameters was observed. Relative maximum change of erector spinae muscle showed a significant regional variation. Correlation testing with age as a covariate revealed significant correlations for baseline psoas fat volume (r = −0.55, p < 0.01) and baseline psoas PDFF (r = −0.52, p = 0.02) with maximum BMI change during the course of the disease. Conclusion: In erector spinae muscles, a regional variation of fat distribution at baseline and relative maximum change of muscle parameters was observed. Our results indicate that psoas muscle PDFF and fat volume could serve as MRI-determined biomarkers for early risk stratification and disease monitoring regarding progression and severity of weight loss in cancer cachexia. MDPI 2021-09-02 /pmc/articles/PMC8431175/ /pubmed/34503243 http://dx.doi.org/10.3390/cancers13174433 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Patzelt, Lisa
Junker, Daniela
Syväri, Jan
Burian, Egon
Wu, Mingming
Prokopchuk, Olga
Nitsche, Ulrich
Makowski, Marcus R.
Braren, Rickmer F.
Herzig, Stephan
Diaz, Mauricio Berriel
Karampinos, Dimitrios C.
MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia
title MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia
title_full MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia
title_fullStr MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia
title_full_unstemmed MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia
title_short MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia
title_sort mri-determined psoas muscle fat infiltration correlates with severity of weight loss during cancer cachexia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431175/
https://www.ncbi.nlm.nih.gov/pubmed/34503243
http://dx.doi.org/10.3390/cancers13174433
work_keys_str_mv AT patzeltlisa mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia
AT junkerdaniela mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia
AT syvarijan mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia
AT burianegon mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia
AT wumingming mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia
AT prokopchukolga mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia
AT nitscheulrich mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia
AT makowskimarcusr mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia
AT brarenrickmerf mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia
AT herzigstephan mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia
AT diazmauricioberriel mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia
AT karampinosdimitriosc mrideterminedpsoasmusclefatinfiltrationcorrelateswithseverityofweightlossduringcancercachexia